Inactive Instrument

News Implanet SA Euronext Paris

Equities

Markets Powered by Alternating Current	Jul. 10
IMPLANET Reports Revenue of €4.1 Million in the First Half of 2024	Jul. 09	BU
Mixed feelings	Jul. 09
IMPLANET Receives FDA Clearance for Its New Hybrid Fixation System Jazz Spinal SystemTM	May. 13	BU
IMPLANET Receives FDA Clearance for Its New Hybrid Fixation System Jazz Spinal System?	May. 13	CI
Shanghai Sanyou Medical's French Unit Gets Nod to Market Jazz Spinal System in US; Shares Up 3%	May. 09	MT
Minutes of IMPLANET’s Ordinary General Meeting held on April 25, 2024	Apr. 25	BU
Implanet: first-quarter sales up slightly	Apr. 10	CF
IMPLANET Reports its 2024 First-Quarter Revenue	Apr. 09	BU
Implanet S.A. Reports Revenue Results for the First Quarter of 2024	Apr. 09	CI
Implanet S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 06	CI
Implanet : Inside Information / News release on accounts, results	Mar. 06	PU
IMPLANET Reports Its 2023 Full-Year Results	Mar. 06	BU
Implanet S.A. Announces Board Changes	Mar. 06	CI
Implanet Completes EUR5.5 Million Capital Raise	Feb. 05	MT
Implanet S.A. announced that it has received ?5 million in funding from Shanghai Sanyou Medical Co., Ltd	Feb. 01	CI
Implanet S.A. Reports Revenue Results for the Fourth Quarter and Full Year 2023	Jan. 15	CI
Sanyou Medical Eyes Controlling Stake in French Peer Implanet For Up to 5 Million Euros	Dec. 11	MT
Implanet S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-10-10	CI
Implanet: share price soars, fund-raising reassures investors	23-09-28	CF

No results for this search